ResearcherUniversity of PennsylvaniaActive in the last 2 years
John Scholler
Matched on ORCID iD 0000-0002-9725-6277; OpenAlex author ID A5091533549. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 2
- Engineering a juxtamembrane-targeting CAR T-cell against mesothelin: a novel binder resilient to shed antigen for enhanced efficacy against ovarian and pancrea… Co-author DOI 10.3389/fimmu.2026.1805950↗
- Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses. Co-author DOI 10.1172/jci.insight.99573↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Carl H. June · 2 shared papers, 2018–2026 · strength 0.35
- Paper Engineering a juxtamembrane-targeting CAR T-cell against mesothelin: a novel binder resilient to shed antigen for enhan… DOI 10.3389/fimmu.2026.1805950↗
- Paper Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed onco… DOI 10.1172/jci.insight.99573↗
- Don L. Siegel · 1 shared paper, 2026 · strength 0.28
- Akseli Hemminki · 1 shared paper, 2018 · strength 0.07
- Keisuke Watanabe · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.